Futura Medical PLC 2024 Annual Report
Company: Futura Medical PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2024
Type: Annual Report
Pages: 100
The report presents FY24 as a year of strategic achievement, with Eroxon launched in over 15 countries and revenue reaching £13.9 million alongside the Group's maiden profit after tax. It reports progress on Eroxon Intense and WSD4000, including a 67-woman sensory study for WSD4000. Its sustainability review focuses on four SDGs and reports workforce gender representation of approximately 65% men and 35% women.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.